Milestone marks the first clinical program for Charcot-Marie-Tooth disease and Vanishing White Matter disease.

Researchers identify that the brain's sensory checkpoint (TRN) undergoes a molecular "upgrade" in adulthood for high-resolution perception.

Expanded collaboration continues to leverage Congruence's proprietary computational drug discovery engine, Revenir™ to deliver Development Candidates in ...

Astronomers with the Hobby-Eberly Telescope Dark Energy Experiment (HETDEX) have used data from the project to make the ...

David Rosenbaum, Ph.D., joins as Chief Development OfficerChristo Shalish joins as Chief Business OfficerBOSTON--(BUSINESS WIRE)--Syntis Bio, Inc. a clinical-stage biopharmaceutical company advancing ...

Many cutting-edge technologies, ranging from augmented reality (AR) and virtual reality (VR) to LiDAR (light detection and ...

Issued on behalf of Helus PharmaVANCOUVER, BC, Feb. 27, 2026 /CNW/ -- Equity-Insider.com News Commentary -- Psychedelic compounds are edging closer to ...

USA News Group News Commentary ? The first psilocybin compound to achieve two positive Phase 3 results in treatment-resistant ...

Background Gut microbiota dysbiosis is linked to autism spectrum disorder (ASD) in children. However, the role of bacterial ...

Market expansion in med derm cross over: Almirall’s Seysara (sarecycline) won NMPA approval for moderate to severe acne (≥9 ...

This study uses a Bayesian framework to characterize latent brain state dynamics associated with memory encoding and performance in children, as measured with functional magnetic resonance imaging.

Overall, only 30% of pupils in grades 1 to 3 are reading at grade level in their home languages. In some languages, up to 25% ...